Bone marrow mononuclear cell therapy for amyotrophic lateral sclerosis. Preliminary results of a randomized, double-blind, stratified controlled, parallel group phase I-II clinical trial

Authors
Category Primary study
ConferenceHuman Gene Therapy
Year 2013
This article has no abstract
Epistemonikos ID: 956be7b9ab97ffd017cc8f2824c9077617da97ca
First added on: Apr 30, 2026